442: Severe maternal infectious morbidity during the second half of pregnancy is an independent risk factor for an SGA neonate Academic Article uri icon


  • Objective The effect of severe maternal infectious morbidity on fetal growth is under debate. Preliminary evidence suggests that such association may be plausible. The objectives of this study were to determine: 1) the association between severe maternal infectious morbidity (SMI) and adverse pregnancy outcome; and 2) The effect of SMI during pregnancy on fetal growth. Study Design This retrospective cohort study included 4771 women who gave birth at our medical center during the study period. The women were allocated into two groups: 1) patients with SMI during the second half of pregnancy (n= 368); and 2) control group comprised of normal pregnant women (NP) who were matched to the SMI group by maternal age, gravidity and parity (n= 4403). Results The SMI group included women with pneumonia (n= 198), pyelonephritis (n= 131), and viral pneumonitis (n= 39). In comparison to the NP …

publication date

  • January 1, 2014